Shanghai Ark Biopharmaceutical Co., Ltd.
PrivateLast Round
Series D
Jul 14, 2022
Est. Valuation
$694.8M
Total Funding Raised
$146.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Shanghai Ark Biopharmaceutical Co., Ltd. is a biopharmaceutical company that discovers and develops therapeutics for unmet medical needs in respiratory and pediatric diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Ark Biopharmaceutical Co., Ltd. Comparables
Compare Shanghai Ark Biopharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enanta Pharmaceuticals | 77% | |
| Pfizer | 77% | |
| Sanofi | 71% | |
Shanghai Ark Biopharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 14, 2022 | ||||
| Series C | Jan 22, 2021 | ||||
| Series A Extension | Feb 6, 2017 | ||||
| Series A | Apr 9, 2015 | ||||
| Angel | Feb 1, 2014 |
Shanghai Ark Biopharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series C |
| Loyal Valley Capital | Series D |
| Oriza Holdings | Series C, Series D |
| Hillhouse Investment | Series C |
| Daoyuan Capital | Series C |
| 德同资本 | Series C |
| Jiangsu Ruihua Investment Holding Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 268% MoM.
- Jan 20, 2026
Monthly visitors increased 189% MoM, reaching 503.
Shanghai Ark Biopharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Ark Biopharmaceutical Co., Ltd.'s valuation, stock price, and market status.